Ep. 397 - What the U.S. midterms mean for biopharma
29 min
Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Midterm election results in the U.S. have short-circuited plans to install a Senate-confirmed FDA commissioner (https://www.biocentury.com/article/661541) and could open a narrow path to bipartisan drug pricing legislation (https://www.biocentury.com/article/661503). On the latest BioCentury This Week podcast, BioCentury’s analysts assess what the results mean for FDA and HHS leadership, user fee negotiations, vaccine regulation, and the prospect of applying most-favored nation pricing to Medicare drug price negotiation. The analysts also unpack full Phase III data (https://www.biocentury.com/article/661524) showing pelacarsen failed across all subgroups and what it means for Lp(a) as a cardio target, highlight SITC abstracts (https://www.biocentury.com/article/661478) on localizing immunotherapy within solid tumors, and discuss argenx’s $550 million upfront buyout (https://www.biocentury.com/article/661512) of Unnatural Products. This episode of the BioCentury This Week podcast has been brought to you by Tigermed (https://www.tigermedgrp.com/). View full story: https://www.biocentury.com/article/661519 #BiotechPolicy #FDA #DrugPricing #Cardiovascular #Immunotherapy 0:01 Sponsor Message: Tigermed 5:06 FDA Leadership After Midterms 12:41 HHS and Drug Pricing 17:34 Pelacarsen Readout at AHA 22:31 SITC Abstract Highlights 25:57 argenx’s Peptide Deal
Episode information is provided by the publisher. Listening takes place on the publisher’s service.
One week after the U.S. midterm elections, join Valérie Beaudoin, one of Canada's most respected commentators on U.S. politics, for a discussion on how Canadian policymakers and officials are digesting the results in Washington. From the new balance of power in Congress to the potential implications for Canada-U.S. relations, trade economic growth, and cross-border policy priorities, we'll explore what the election outcome could mean for Canada in the months ahead. Recorded on November 10, 2026. -- Optique canadienne sur les élections américaines de mi-mandat – Valérie Beaudoin Pour une version avec des sous-titres français, veuillez consulter Une semaine après les élections de mi-mandat aux États-Unis, Valérie Beaudoin, l’une des commentatrices de la politique américaine les plus respectées du Canada, discute des façons dont les décideurs canadiens et Ottawa ont réagi aux résultats à Washington. Du nouvel équilibre des pouvoirs au Congrès aux répercussions possibles sur les relations
We've all heard of the law of attraction – but in this video, Tony Robbins gives a new take on it... one that you might not have heard before. Uploaded 28-07-21 What if instead of it being all about getting the things that you want, it was about becoming the person who would have those things? What does that mean? It means if you want a passionate and loving relationship, you become a passionate and loving person. If you want to grow your business beyond your wildest dreams, you become a person who focuses on growth and learning. If you want to live a long and vital life, you become a person who does that right now, today. So what's it really about? It's about raising your standards. It's about creating the energy in your body, in your mind and in your surroundings that propels you toward the life that you want. This video was originally taken from Tony Robbins' Unleash the Power Within Event. Unleash the Power Within is the signature event designed by entrepreneur, best-selling author
Viewers like you help make PBS (Thank you ) . Support your local PBS Member Station here: https://to.pbs.org/DonateSPACE Uploaded 10-10-18 Physics seems to be telling us that it’s possible to simulate the entire universe on a computer smaller than the universe. You can further support us on Patreon at https://www.patreon.com/pbsspacetime Space Time Challenge Winners Jin Du Loren Booker Kevin Selva Prasanna May Awbin John Reza Ian Grams Challenge Winners: Please [email protected] with your name, address, US t-shirt size – small, medium, large, extra large, or extra-extra-large and let us know which T you’d like. Get your own Space Time t-shirt at http://bit.ly/1QlzoBi Tweet at us! @pbsspacetime Facebook: facebook.com/pbsspacetime Email us! pbsspacetime [at] gmail [dot] com Comment on Reddit: http://www.reddit.com/r/pbsspacetime Help translate our videos! Previous Episode: How to Detect Extra Dimensions Hosted by Matt O'Dowd Written by Matt O'Dowd Graphics by Luke Maroldi Assistant
#JimRohnMotivation #JimRohn #JimRohnSpeech In this Jim Rohn Motivation video, discover the 10 timeless life skills that separate those who thrive from those who stay stuck. These aren’t shortcuts or gimmicks—they’re real, buildable disciplines that strengthen your character, sharpen your focus, and help you lead your life with intention. Key Topics From This Motivational Video: Why emotional control is more powerful than raw talent How daily focus compounds into massive results The secret edge of people who delay gratification Why adaptability is more valuable than rigid plans How self-awareness and discipline shape your entire destiny This Jim Rohn-style motivational video breaks down what it truly takes to lead a strong, resilient, purpose-driven life. You’ll learn how to sharpen skills like focus, emotional regulation, adaptability, and decision-making—so you stop chasing the next hack and start becoming the kind of person success finds. These life skills are simple, transferable, a
This Sunday on the Aussie Real Estate Podcast, Craig revisits the week’s key property stories, from AI-driven data centre expansion and its impact on electricity and water demand to off-the-plan buying risks. Plus, discover why Sydney buyers are negotiating major discounts and the true upfront cost of buying an Australian home. ► Email: [email protected]
Is the property downturn shifting from city to city, or are national headlines hiding what is happening on the ground? On this week's Australian Property Podcast, Pete Wargent and Chris Bates look at changing listings, buyer demand and price movements across Australia's housing markets. If you're considering a first home, an upgrade or an investment property, this episode offers questions to ask before acting. Check current lending and tax rules, and seek qualified personal advice rather than treating a podcast discussion as a recommendation. Episode resources Show partner resources Rask resources – Pete's Buyers Agency (https://www.allenwargent.com.au/) – All services (https://bit.ly/R-services) – Financial Planning (https://bit.ly/R-plan) – Invest with us (https://bit.ly/R-invest) – Access Show Notes (https://bit.ly/R-notes) – Ask a question (https://bit.ly/R-quest) – We love feedback! (https://raskau.typeform.com/to/ZbfHy6IP) – Instagram: @rask.invest (https://www.instagram.com/rask
J&J will pay $2.2 billion upfront to acquire Ollin (https://www.biocentury.com/article/661621), a Texas-based NewCo with China-sourced assets, gaining a late-stage VEGF x Ang2 bispecific for wet AMD and diabetic macular edema. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the terms of the deal, what it says about NewCos as an exit path and Blackstone Life Sciences’ role in funding Phase III. The analysts also assess how a growing neoantigen vaccine pipeline (https://www.biocentury.com/article/661439) is testing the modality’s reach after Merck and Moderna’s Phase III win in melanoma, and the White House push (https://www.biocentury.com/article/661564) that has put Heidi Overton back in play ahead of the Nov. 18 Senate HELP Committee vote on her nomination as FDA commissioner. This episode of the BioCentury This Week podcast has been brought to you by Tigermed (https://www.tigermedgrp.com/). View full story: https://www.biocentury.com/article/661638 #NewCos #
Rising first-in-class innovation, faster IND reviews and deep patient pools are drawing global biotechs to China, even as U.S. outbound investment restrictions loom. In a special edition of the BioCentury This Week podcast recorded live at the 13th BioCentury-BayHelix China Healthcare Summit in Shanghai, BioCentury’s Jeff Cranmer, Simone Fishburn and Josh Berlin are joined by Kali Therapeutics CEO Weihao Xu, Charles River’s Matthew Hewitt and Aerska CEO Jack O’Meara to discuss key themes from the event. The panel assesses what the COINS Act could mean for U.S. investment in China biotech and how investors may adapt, how China’s 30-day IND review and new investigator-initiated trial rules are reshaping clinical strategy, and what dealmaking reveals about the country’s growing first-in-class pipeline. They also preview BioCentury’s East-West Summit in Seoul (https://conferences.biocentury.com/east-west-summit), March 15-17. View full story: https://www.biocentury.com/article/661483 #Chin
Environmental marketing claims should require independent verification.
Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.
Do you agree or disagree?
Common Quandary
A Common Quandary to discuss
Another conversation to explore, separate from this news story.
Your new television goes on sale elsewhere. Can you return it and buy the identical one cheaper?
A week after buying a television, another store offers the same model for much less. Your retailer refuses to match the price but allows unopened-looking returns. You could carefully repack the perfectly functional set.
Is a generous return policy permission to reverse a deal for any reason?